People: Editas Medicine Inc (EDIT.OQ)
Dr. Charles Albright Ph.D., is a Chief Scientific Officer of the EDITAS MEDICINE, INC. since August 2016. Prior to joining our company, Dr. Albright served in a variety of roles at Bristol-Myers Squibb Company, a biopharmaceutical company, from January 2004 to August 2016, serving most recently as the Vice President, Genetically Defined Diseases and Genomics. Dr. Albright received his B.S. in chemical engineering and a Ph.D. in biology from the Massachusetts Institute of Technology..
|Total Annual Compensation, USD||523,477|
|Restricted Stock Award, USD||--|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||1,864,420|
|Fiscal Year Total, USD||2,387,900|